Literature DB >> 10896781

CBP1 associates with the Dictyostelium cytoskeleton and is important for normal cell aggregation under certain developmental conditions.

A Dharamsi1, D Tessarolo, B Coukell, J Pun.   

Abstract

In cells of the eukaryotic microorganism Dictyostelium discoideum, at least eight small, four-EF-hand Ca(2+)-binding proteins of unknown function are expressed at specific times during development. One of these proteins, calcium-binding protein 1 (CBP1), first appears just prior to cell aggregation and then is present at relatively constant levels throughout development. To determine a role for CBP1 during development, the protein was used as bait in a yeast two-hybrid screen to reveal putative CBP1-interacting proteins. Two proteins identified in this screen were the actin-binding proteins, protovillin and EF-1alpha. Using an in vitro binding assay, both of these proteins were found to interact with CBP1 in the absence of Ca(2+), but the interaction of CBP1 with EF-1alpha was increased substantially by Ca(2+). CBP1 was also shown by fluorescence microscopy and by binding assays to associate with the actin cytoskeleton of Dictyostelium cells during development, and these interactions were partially Ca(2+)-dependent. cbpA-null cells grew normally, but under certain developmental conditions, cell aggregation was prolonged and irregular. This defect in aggregation appeared to be related to a general reduction in cell motility rather than to a decrease in the ability of the cells to respond to the chemoattractant cAMP. Together, these results suggest that CBP1 might function to help regulate the reorganization of the Dictyostelium actin cytoskeleton during cell aggregation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896781     DOI: 10.1006/excr.2000.4950

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Genome-wide expression analyses of gene regulation during early development of Dictyostelium discoideum.

Authors:  Negin Iranfar; Danny Fuller; William F Loomis
Journal:  Eukaryot Cell       Date:  2003-08

2.  The Ca2+/calcineurin-regulated cup gene family in Dictyostelium discoideum and its possible involvement in development.

Authors:  Barrie Coukell; Yi Li; John Moniakis; Anne Cameron
Journal:  Eukaryot Cell       Date:  2004-02

3.  In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype.

Authors:  Abdul Mannan Baig; Junaid Iqbal; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2013-05-13       Impact factor: 5.191

Review 4.  Proteins of the Nucleolus of Dictyostelium discoideum: Nucleolar Compartmentalization, Targeting Sequences, Protein Translocations and Binding Partners.

Authors:  Danton H O'Day
Journal:  Cells       Date:  2019-02-17       Impact factor: 6.600

5.  The Calmodulin-like calcium binding protein EhCaBP3 of Entamoeba histolytica regulates phagocytosis and is involved in actin dynamics.

Authors:  Saima Aslam; Sudha Bhattacharya; Alok Bhattacharya
Journal:  PLoS Pathog       Date:  2012-12-27       Impact factor: 6.823

6.  Rad53 homologue forkhead-associated kinase A (FhkA) and Ca2+-binding protein 4a (CBP4a) are nucleolar proteins that differentially redistribute during mitosis in Dictyostelium.

Authors:  Andrew Catalano; Danton H O'Day
Journal:  Cell Div       Date:  2013-04-12       Impact factor: 5.130

7.  CBP7 Interferes with the Multicellular Development of Dictyostelium Cells by Inhibiting Chemoattractant-Mediated Cell Aggregation.

Authors:  Byeonggyu Park; Dong-Yeop Shin; Taeck Joong Jeon
Journal:  Mol Cells       Date:  2018-01-29       Impact factor: 5.034

8.  Proteomic and Transcriptomic Profiling Identifies Early Developmentally Regulated Proteins in Dictyostelium Discoideum.

Authors:  Óscar González-Velasco; Javier De Las Rivas; Jesus Lacal
Journal:  Cells       Date:  2019-10-01       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.